- WHO releases report on state of development of antibacterials🔍
- 2023 Antibacterial agents in clinical and preclinical development🔍
- WHO publishes latest report on development of antibacterial agents ...🔍
- Antibacterial agents in preclinical and clinical development🔍
- WHO Antibacterial Pipeline Review🔍
- Recent advances and challenges in antibacterial drug development🔍
- Antibiotics in the clinical pipeline as of December 2022🔍
- WHO 2020 report on the antibacterial production and development ...🔍
WHO publishes latest report on development of antibacterial agents ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical development ...
2023 Antibacterial agents in clinical and preclinical development
This report presents an analysis of antibacterial agents in preclinical (fourth annual review) and clinical (sixth annual review) development.
WHO publishes latest report on development of antibacterial agents ...
The annual report aims to improve the research and development pipeline to address infections caused by drug-resistant bacteria most threatening ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical ...
Antibacterial agents in preclinical and clinical development
The report shows that 97 antibacterial agents or combinations that include at least one new therapeutic entity are in clinical development.
WHO Antibacterial Pipeline Review: Update thru 31 Dec 2023
The report: 2023 Antibacterial agents in clinical and preclinical development: an overview and analysis and a press release about the report.
Recent advances and challenges in antibacterial drug development
Only one of these was approved in the last two years. This translates to an average duration of approximately 10.1 years for a new antimicrobial agent to ...
Antibiotics in the clinical pipeline as of December 2022 - Nature
The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clearly attracted ...
WHO 2020 report on the antibacterial production and development ...
In April, 2021, WHO published their report on antibacterial agents in the clinical and preclinical development pipeline in 2020, to assess which ones might ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) today released its latest report on antibacterial agents, including antibiotics, in clinical and ...
Antibiotics under development insufficient to tackle antimicrobial ...
After a gap of two years, the World Health Organization (WHO) has released its latest report that presents an analysis of antibacterial agents ...
2021 Antibacterial agents in clinical and preclinical development
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development ...
International Journal of Antimicrobial Agents - ScienceDirect.com
Read the latest articles of International Journal of Antimicrobial Agents at ScienceDirect.com, Elsevier's leading platform of peer-reviewed scholarly ...
WHO releases report on state of development of antibacterials
The World Health Organization (WHO) has released its latest report on antibacterial agents, including antibiotics, in clinical and preclinical development ...
10 × '20 Progress—Development of New Drugs Active Against Gram ...
The current report updates the status of development and approval of systemic antibiotics in the United States as of early 2013. Only 2 new antibiotics have ...
Antibacterial agents in clinical development: an analysis ... - ReliefWeb
The report identifies 51 new antibiotics and biologicals in clinical development to treat priority antibiotic-resistant pathogens, as well as tuberculosis.
Antimicrobial resistance | European Medicines Agency (EMA)
EMA plays a vital role in the global response to the threat of antimicrobial resistance, by: supporting the development of new medicines and treatment ...
Antimicrobial Agents and Chemotherapy - ASM Journals
In this episode we will debrief and analyze the possible impact of these meetings and consequences for the future of AMR research and antimicrobial development.
A Review of Antibacterial Candidates with New Modes of Action
World Health Organization. 2021 Antibacterial agents in clinical and preclinical development: an overview and analysis; World Health ...